Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With Alirocumab
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Elevated lipoprotein(a) (Lp(a)) hinders plaque regression in acute myocardial infarction patients treated with alirocumab and statins. High Lp(a) may explain residual cardiovascular risk despite optimal lipid control.
Area Of Science
- Cardiology
- Atherosclerosis Research
- Lipid Metabolism
Background
- Elevated lipoprotein(a) (Lp(a)) is a known risk marker for atherosclerotic disease.
- The precise mechanisms linking Lp(a) to atherosclerosis progression are not fully understood.
- Investigating Lp(a)'s role in plaque changes during intensive lipid-lowering therapy is crucial.
Purpose Of The Study
- To examine the association between baseline Lp(a) levels and changes in coronary atherosclerosis.
- To assess the impact of Lp(a) on plaque regression in patients receiving alirocumab plus high-intensity statins.
- To elucidate potential mechanisms for residual cardiovascular risk in patients with high Lp(a).
Main Methods
- The PACMAN-AMI trial randomized 300 acute myocardial infarction patients to alirocumab or placebo with high-intensity statins.
- Serial intravascular ultrasound, optical coherence tomography, and near-infrared spectroscopy were used to assess coronary plaque.
- End points included percent atheroma volume, fibrous cap thickness, and lipid core burden.
Main Results
- Alirocumab significantly reduced atheroma volume and lipid burden, and increased fibrous cap thickness compared to placebo.
- In the alirocumab group, patients with higher baseline Lp(a) (≥98 nmol/L) showed a smaller reduction in lipid burden compared to those with lower Lp(a).
- Changes in atheroma volume and fibrous cap thickness did not significantly differ based on baseline Lp(a) levels.
Conclusions
- Elevated baseline Lp(a) is associated with attenuated plaque lipid regression despite intensive alirocumab and statin therapy.
- This finding may explain the persistent cardiovascular risk observed in individuals with high Lp(a) even with optimal lipid management.
- Understanding Lp(a)'s impact is vital for refining risk stratification and treatment strategies in atherosclerotic disease.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Overview
In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...